Orthofix International reported $-2.19M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Dexcom USD 340.7M 40.7M Dec/2025
EDAP TMS EUR -4.91M 597K Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD 4.31M 11.13M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Orthofix International USD -2.19M 20.07M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Smith & Nephew USD 469M 70M Dec/2025
STAAR Surgical USD -20.65M 39.44M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Surmodics USD -5.9M 1.61M Jun/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Veracyte USD 29.97M 10.66M Mar/2026
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025